If you’re looking up the low platelet count ICD-10 code, the primary code you need is D69.6 — Thrombocytopenia, unspecified. But coding thrombocytopenia correctly goes beyond that single entry. Depending on the underlying cause, you may need D69.3 (immune thrombocytopenic purpura), D69.59 (other secondary thrombocytopenia), or D69.41 (Evans syndrome), among others. Choosing the right code matters — it drives reimbursement, tracks outcomes, and communicates clinical reasoning across care teams.
This article provides a comprehensive insight into low platelet count ICD-10 diagnosis and management strategies, covering the specific codes, clinical thresholds that guide treatment decisions, and evidence-based approaches to workup and therapy. Whether you’re a coder, clinician, or student, this is designed to be the reference you actually need.
What Counts as a Low Platelet Count?
Thrombocytopenia is defined as a platelet count below 150,000/µL (150 × 10⁹/L). The normal range runs from 150,000 to 400,000/µL. But not all low counts carry the same clinical weight — a count of 140,000 is often clinically irrelevant, while a count below 10,000 can be life-threatening.
Here’s how severity is typically classified:
| Severity | Platelet Count (per µL) | Clinical Significance |
|---|---|---|
| Mild | 100,000–149,000 | Usually asymptomatic; rarely requires treatment |
| Moderate | 50,000–99,000 | Increased bruising; surgical bleeding risk rises |
| Severe | 20,000–49,000 | Spontaneous mucosal bleeding possible |
| Critical | <20,000 | Risk of spontaneous intracranial hemorrhage; often requires intervention |
Most surgeons want platelets above 50,000 before operating, and above 80,000–100,000 for neurosurgery or epidural placement. Spontaneous serious bleeding typically doesn’t occur until counts drop below 10,000–20,000.
ICD-10 Codes for Thrombocytopenia: The Full Picture
Coding thrombocytopenia accurately requires identifying the cause. Using D69.6 (unspecified) is acceptable when the etiology is unknown, but once a cause is established, the code should be updated. Here are the most commonly used ICD-10 codes:
| ICD-10 Code | Description | Common Scenario |
|---|---|---|
| D69.3 | Immune thrombocytopenic purpura (ITP) | Autoimmune platelet destruction; most common cause in otherwise healthy adults |
| D69.41 | Evans syndrome | ITP combined with autoimmune hemolytic anemia |
| D69.42 | Congenital and hereditary thrombocytopenic purpura | Wiskott-Aldrich syndrome, Bernard-Soulier, MYH9 disorders |
| D69.59 | Other secondary thrombocytopenia | Due to infection, medications, or other identified external cause |
| D69.6 | Thrombocytopenia, unspecified | Cause not yet determined; initial encounter |
| D75.82 | Heparin-induced thrombocytopenia (HIT) | Platelet drop >50% after heparin exposure; prothrombotic state |
| O99.11 | Thrombocytopenia complicating pregnancy | Gestational thrombocytopenia (accounts for ~75% of low platelets in pregnancy) |
| P61.0 | Transient neonatal thrombocytopenia | Newborn with maternal antibody-mediated platelet destruction |
Coding tip: When thrombocytopenia is drug-induced, you should also assign a code from T36–T50 to identify the responsible medication, along with the appropriate 7th character for the encounter type.
Causes of Thrombocytopenia: A Clinical Framework
The causes break down neatly into three mechanisms. This framework is the backbone of any hematology workup:
1. Decreased Production (Bone Marrow Problem)
- Aplastic anemia — pancytopenia from marrow failure
- Myelodysplastic syndromes — ineffective hematopoiesis
- Leukemia or marrow infiltration — crowding out normal megakaryocytes
- B12 or folate deficiency — impaired DNA synthesis in precursor cells
- Chronic alcohol use — directly toxic to megakaryocytes
2. Increased Destruction (Peripheral Problem)
- ITP — antiplatelet antibodies target GPIIb/IIIa or GPIb/IX
- Thrombotic thrombocytopenic purpura (TTP) — ADAMTS13 deficiency; a medical emergency
- Hemolytic uremic syndrome (HUS) — microangiopathic process, often post-infectious
- Disseminated intravascular coagulation (DIC) — consumptive coagulopathy
- Heparin-induced thrombocytopenia (HIT) — paradoxically causes clotting, not bleeding
3. Sequestration or Dilution
- Hypersplenism — an enlarged spleen can trap up to 90% of circulating platelets (normal spleen holds ~30%)
- Massive transfusion — dilutional effect from large-volume resuscitation
Diagnostic Workup: What Tests to Order
A systematic approach prevents missed diagnoses. Here’s the standard workup for new-onset thrombocytopenia:
- CBC with peripheral blood smear — rule out pseudothrombocytopenia (platelet clumping in EDTA), look for schistocytes (suggests TTP/HUS/DIC), and assess other cell lines
- Reticulocyte count and LDH — elevated in hemolytic processes
- Coagulation studies (PT/INR, aPTT, fibrinogen, D-dimer) — abnormal in DIC
- HIV and hepatitis C serology — both can cause ITP-like pictures
- H. pylori testing — associated with ITP; eradication can improve counts
- Liver function tests and imaging — assess for cirrhosis and splenomegaly
- ADAMTS13 activity — if TTP is suspected (level <10% is diagnostic)
- Bone marrow biopsy — reserved for cases where production failure is suspected or diagnosis remains unclear
One often-overlooked step: always check the peripheral smear. Pseudothrombocytopenia from EDTA-dependent platelet clumping occurs in roughly 0.1% of the population and can trigger unnecessary workups.
Management Strategies by Cause
Immune Thrombocytopenic Purpura (ITP)
Treatment is generally not needed unless platelets drop below 30,000/µL or the patient is bleeding. First-line therapy is corticosteroids (dexamethasone 40 mg daily × 4 days, or prednisone 1 mg/kg/day). Response rates to steroids are around 60–80%, but relapse is common.
Second-line options include thrombopoietin receptor agonists (eltrombopag, romiplostim), rituximab, and splenectomy — which still achieves durable remission in approximately 60–70% of patients.
Thrombotic Thrombocytopenic Purpura (TTP)
This is a hematologic emergency. Untreated mortality exceeds 90%. Treatment is plasma exchange (plasmapheresis) plus corticosteroids, ideally started within hours of clinical suspicion. Caplacizumab, an anti–von Willebrand factor nanobody, has become a key addition, reducing time to platelet normalization.
Never transfuse platelets in suspected TTP — it can worsen microvascular thrombosis.
Heparin-Induced Thrombocytopenia (HIT)
Stop all heparin immediately and start a non-heparin anticoagulant (argatroban, bivalirudin, or fondaparinux). Platelet transfusion is generally avoided unless there’s life-threatening bleeding. Confirm with a serotonin release assay or PF4/heparin ELISA.
Thrombocytopenia in Pregnancy
Gestational thrombocytopenia (counts usually 100,000–149,000) accounts for about 75% of cases and resolves postpartum without intervention. However, platelet counts below 70,000 should prompt evaluation for HELLP syndrome, preeclampsia, or ITP.
When to See a Doctor
Seek urgent medical evaluation if you experience any of the following:
- Petechiae — pinpoint red/purple spots, especially on the legs, that don’t blanch with pressure
- Bleeding from gums or nose that won’t stop with standard pressure
- Blood in urine or stool
- Unusually heavy menstrual periods
- Severe headache with known low platelet count — this could indicate intracranial bleeding
- Any platelet count below 50,000/µL warrants hematology consultation
Frequently Asked Questions
What is the ICD-10 code for low platelet count?
The most commonly used code is D69.6 (thrombocytopenia, unspecified). However, when the cause is identified — such as ITP (D69.3), HIT (D75.82), or drug-induced thrombocytopenia (D69.59) — a more specific code should replace it.
At what platelet count should I worry?
Mild thrombocytopenia (100,000–149,000) often needs only monitoring. Counts below 50,000 increase surgical bleeding risk. Below 20,000, spontaneous bleeding becomes a real concern, and below 10,000, intracranial hemorrhage risk rises significantly.
Can low platelets fix themselves?
Yes, in many cases. Viral infections commonly cause transient thrombocytopenia that resolves in weeks. Gestational thrombocytopenia normalizes after delivery. Drug-induced cases typically recover within 5–10 days of stopping the offending medication. However, chronic causes like ITP or bone marrow disorders usually require ongoing management.
What’s the difference between ITP and TTP?
Both cause low platelets, but through entirely different mechanisms. ITP is autoimmune destruction of platelets — patients bleed. TTP involves widespread microvascular clotting that consumes platelets — patients clot and can develop organ damage, strokes, and renal failure. TTP is a medical emergency; ITP rarely is.
Does D69.6 cover thrombocytopenia caused by chemotherapy?
No. Chemotherapy-induced thrombocytopenia should be coded with D69.59 (other secondary thrombocytopenia) along with the appropriate adverse effect code from T45.1X5A for antineoplastic drugs. Accurate coding here is essential for tracking treatment toxicity and supporting medical necessity for platelet transfusions.
